Registrant : Organisation or self-employed individual
Sections
| Section: |
II - In-house lobbyists and trade/professional associations |
| and more precisely: |
Companies & groups |
Person with legal responsibility
| Surname, Name: |
Mr
Karl-Ludwig Dr. Kley
|
| Position: |
Vorsitzender der Geschäftsleitung |
Permanent person in charge of EU relations
| Surname, Name: |
Mrs
Friederike Segeberg
|
| Position: |
Manager Public Affairs |
Contact details:
| Contact details of organisation's head office: |
250 Frankfurter Strasse
Darmstadt 64293
GERMANY
|
| Telephone number: |
(+06151) 720 |
| Fax number: |
(+) |
| Other contact information: |
|
Goals / remit
| Goals / remit of the organisation: |
Merck is a leading pharmaceutical, chemical and life science company with total revenues of € 11.2 billion in 2012, a history that began in 1668, and a future shaped by approx. 39,000 employees in 66 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
|
The organisation's fields of interests are:
|
|
Number of persons engaged in activities falling under the scope of the Transparency Register
| Number of persons: |
15
|
|
Complementary information:
|
|
Persons accredited for access to European Parliament premises
Activities
Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:
|
Activities in the policy areas of pharma and health legislation, Energy & Climate, Environment and Chemicals legislations, Biotechnology, Taxation and Research and Development.
Merck is committed to work in partnerships with the European institutions to support policies and actions that facilitates patient access to treatments for unmet medical needs, especially chronic and rare diseases, as well as aspects supporting Europe' R&D in innovative healthcare technologies.
|
Fields of interest for e-mail alerts on consultations and roadmaps;
| Fields declared by the organisation: |
- Climate Action
- Competition
- Consumer Affairs
- Customs
- Development
- Economic and Financial Affairs
- Employment and Social Affairs
- Energy
- Enterprise
- Environment
- Food Safety
- General and Institutional Affairs
- Humanitarian Aid
- Internal Market
- Public Health
- Research and Technology
- Trade
|
Networking
Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.
|
Merck KGaA is a member of BIO (US), CEFIC (EU),EFPIA (EU), EuropaBio (EU),InterPharma (CH), VCI (DE)and VfA (DE).
|
Financial data
| Financial year: |
01/2012
-
12/2012
|
|
Estimated costs to the organisation directly related to representing interests to EU institutions in that year:
|
400,000 €
|
|
Amount and source of funding received from the EU institutions in financial year n-1 of registration
|
|
Procurement:
|
0 €
|
|
Grants:
|
1,055,000 €
|
Other (financial) information provided by the organisation:
|
|
|
